Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
SARS-CoV-2 Donor-Recipient Immunity Transfer - Drug Trials For Money - Paid Clinical Trials

SARS-CoV-2 Donor-Recipient Immunity Transfer

SARS-CoV-2 Donor-Recipient Immunity Transfer
Conditions:   Accelerated Phase CML, BCR-ABL1 Positive;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Lymphocytic Leukemia;   Chronic Phase CML, BCR-ABL1 Positive;   COVID-19 Infection;   Hematopoietic and Lymphoid Cell Neoplasm;   Hodgkin Lymphoma;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Myeloproliferative Neoplasm;   Non-Hodgkin Lymphoma
Interventions:   Procedure: Biospecimen Collection;   Other: Diagnostic Laboratory Biomarker Analysis;   Other: Electronic Health Record Review;   Other: Questionnaire Administration
Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 15, 2020 / by / in
Comments